Literature DB >> 25921396

Making a case for albumin – a highly promising drug-delivery system.

Angelica M Merlot1, Danuta S Kalinowski, Zaklina Kovacevic, Patric J Jansson, Darius J R Lane, Michael L-H Huang, Sumit Sahni, Des R Richardson.   

Abstract

Keywords:  albumin; diabetes; drug carriers; drug-delivery; oncology; rheumatoid arthritis

Mesh：

Substances：

Year:  2015        PMID： 25921396     DOI： 10.4155/fmc.15.15

Source DB:  PubMed          Journal:  Future Med Chem        ISSN： 1756-8919            Impact factor:   3.808


× No keyword cloud information.
  5 in total

1.  Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infection.

Authors:  Yanhua Ding; Jinfeng Lou; Hong Chen; Xiaojiao Li; Min Wu; Cuiyun Li; Jingrui Liu; Chengjiao Liu; Qingmei Li; Hong Zhang; Junqi Niu
Journal:  Br J Clin Pharmacol       Date:  2016-12-20       Impact factor: 4.335

2.  Albumin-Based Transport of Nonsteroidal Anti-Inflammatory Drugs in Mammalian Blood Plasma.

Authors:  Mateusz P Czub; Katarzyna B Handing; Barat S Venkataramany; David R Cooper; Ivan G Shabalin; Wladek Minor
Journal:  J Med Chem       Date:  2020-06-17       Impact factor: 7.446

Review 3.  Bispecific antibodies and their applications.

Authors:  Gaowei Fan; Zujian Wang; Mingju Hao; Jinming Li
Journal:  J Hematol Oncol       Date:  2015-12-21       Impact factor: 17.388

Review 4.  The development of bispecific antibodies and their applications in tumor immune escape.

Authors:  Xiaolong Zhang; Yuanyuan Yang; Dongmei Fan; Dongsheng Xiong
Journal:  Exp Hematol Oncol       Date:  2017-05-02

5.  The Release of a Highly Cytotoxic Paullone Bearing a TEMPO Free Radical from the HSA Hydrogel: An EPR Spectroscopic Characterization.

Authors:  Ana Vesković; Đura Nakarada; Olga Vasiljević; Anatolie Dobrov; Gabriella Spengler; Éva A Enyedy; Vladimir B Arion; Ana Popović Bijelić
Journal:  Pharmaceutics       Date:  2022-05-30       Impact factor: 6.525
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.